Viewing Study NCT06648200


Ignite Creation Date: 2025-12-26 @ 12:17 PM
Ignite Modification Date: 2026-01-13 @ 10:39 AM
Study NCT ID: NCT06648200
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-10-18
First Post: 2024-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-11-01
Start Date Type: ESTIMATED
Primary Completion Date: 2030-09-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2030-09-01
Completion Date Type: ESTIMATED
First Submit Date: 2024-10-09
First Submit QC Date: None
Study First Post Date: 2024-10-18
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-16
Last Update Post Date: 2024-10-18
Last Update Post Date Type: ACTUAL